NCT04952922View on ClinicalTrials.gov

Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

May 13, 2024

Study Completion Date

May 13, 2024

Conditions
Recurrent Oropharynx Carcinoma
Interventions
OTHER

Treatment for recurrent oropharyngeal cancer (curative/ palliative)

Open salvage surgery, transoral robotic surgery, palliative chemotherapy, immunotherapy.

Trial Locations (1)

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

All Listed Sponsors
collaborator

Imperial College London

OTHER

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT04952922 - Changes to Function and Quality of Life and Patient Experience for Patients Undergoing Treatments for Recurrent Oropharyngeal Cancer | Biotech Hunter | Biotech Hunter